Tomás Sobrino Selected Research

Tomás Sobrino Research Topics

Disease

52	Stroke (Strokes) 06/2022 - 01/2006
50	Ischemic Stroke 06/2022 - 01/2007
24	Inflammation (Inflammations) 06/2022 - 01/2006
18	Brain Ischemia (Cerebral Ischemia) 01/2022 - 06/2007
12	Infarction (Infarctions) 01/2019 - 01/2006
10	Periodontitis 06/2022 - 01/2019
9	Migraine Disorders (Migraine) 03/2020 - 05/2007
9	Ischemia 10/2018 - 01/2006
8	Hematoma 07/2021 - 01/2007
8	Cerebral Hemorrhage 12/2020 - 12/2009
6	Brain Injuries (Brain Injury) 01/2018 - 01/2008
5	Keratoconus 02/2021 - 10/2010
4	Obesity 02/2022 - 01/2019
4	Leukoaraiosis 01/2022 - 10/2009
4	Necrosis 12/2021 - 01/2016
3	Body Weight (Weight, Body) 02/2022 - 01/2019
3	Lacunar Stroke 01/2019 - 01/2006
3	Embolic Stroke 01/2019 - 07/2013
3	Edema (Dropsy) 01/2013 - 01/2007
3	Brain Edema (Cerebral Edema) 12/2012 - 01/2007
2	Cerebral Infarction 01/2021 - 01/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2020
2	Hypothermia 01/2020 - 01/2016
2	Atrial Fibrillation 01/2019 - 07/2013
2	Hemorrhage 01/2018 - 06/2017
2	Asphyxia (Suffocation) 01/2017 - 01/2016
2	Transient Ischemic Attack 01/2017 - 08/2013
2	Hemorrhagic Stroke 04/2010 - 01/2009
1	Peri-Implantitis 10/2021
1	Cognitive Dysfunction 03/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021

Drug/Important Bio-Agent (IBA)

25	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2006
19	Glutamic Acid (Glutamate)FDA Link 06/2022 - 03/2006
17	Interleukin-6 (Interleukin 6)IBA 06/2022 - 01/2006
11	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2007
9	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2022 - 01/2009
8	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2006
8	EnzymesIBA 01/2022 - 06/2011
8	Oxaloacetic Acid (Oxalacetic Acid)IBA 01/2017 - 06/2011
7	Neuroprotective AgentsIBA 01/2022 - 06/2008
7	Transaminases (Aminotransferases)IBA 01/2017 - 06/2011
6	Fibronectins (Fibronectin)IBA 06/2022 - 06/2007
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2011
6	IronIBA 08/2021 - 01/2007
6	erucylphosphocholineIBA 04/2017 - 10/2007
5	C-Reactive ProteinIBA 06/2022 - 01/2018
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 12/2009
4	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2022 - 01/2009
4	Interleukin-10 (Interleukin 10)IBA 10/2021 - 06/2013
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2020 - 05/2007
4	Peptides (Polypeptides)IBA 01/2020 - 10/2009
3	Therapeutic UsesIBA 01/2022 - 01/2017
3	Biological ProductsIBA 01/2021 - 01/2008
3	PTX3 proteinIBA 03/2020 - 01/2018
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 06/2007
3	Amyloid beta-PeptidesIBA 01/2020 - 10/2009
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 12/2009
3	Endothelin-1 (Endothelin 1)IBA 06/2015 - 07/2008
3	NeuroserpinIBA 05/2011 - 02/2011
3	Ferritins (Ferritin)IBA 04/2010 - 01/2007
2	Vitamin D FDA LinkGeneric 06/2022 - 03/2021
2	LigandsIBA 06/2022 - 06/2011
2	InterleukinsIBA 02/2022 - 06/2011
2	AdiponectinIBA 02/2022 - 01/2018
2	LeptinIBA 02/2022 - 01/2018
2	CeramidesIBA 01/2022 - 01/2021
2	SphingolipidsIBA 01/2022 - 01/2021
2	LipidsIBA 10/2021 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2021 - 10/2020
2	Amyloid (Amyloid Fibrils)IBA 07/2021 - 01/2013
2	tau Proteins (tau Protein)IBA 07/2021 - 01/2020
2	Matrix Metalloproteinases (MMPs)IBA 07/2021 - 07/2020
2	Type A Botulinum Toxins (Botox)FDA Link 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 07/2020 - 01/2018
2	Calcitonin Gene-Related PeptideIBA 10/2019 - 07/2012
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2019 - 02/2011
2	Collagenases (Collagenase)FDA Link 10/2018 - 07/2015
2	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 01/2006
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2017 - 01/2016
2	Cytidine Diphosphate Choline (Citicoline)IBA 01/2013 - 07/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2012 - 06/2008
2	Excitatory Amino Acid AntagonistsIBA 02/2012 - 03/2006
2	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 07/2008 - 06/2007
1	Fibrinogen (Factor I)FDA Link 06/2022
1	Chaperonin 60IBA 06/2022
1	Hormones (Hormone)IBA 02/2022
1	fibroblast growth factor 21IBA 02/2022
1	Drug CarriersIBA 01/2022
1	Steroidogenic Factor 1IBA 10/2021
1	AMP-Activated Protein KinasesIBA 10/2021
1	CholesterolIBA 10/2021
1	LDL CholesterolIBA 10/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2021
1	Chelating AgentsIBA 08/2021
1	AntioxidantsIBA 08/2021
1	Deferoxamine (Desferal)FDA LinkGeneric 08/2021

Therapy/Procedure

24	Therapeutics 06/2022 - 01/2006
4	Thrombolytic Therapy 01/2021 - 01/2007
2	Aftercare (After-Treatment) 06/2007 - 01/2007
1	Intravenous Injections 10/2021